CROSSROADS STRATEGIES, LLC for ALKERMES, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Alcohol and Drug Abuse ALC
S.3040/H.R.5926, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; H.R.5393/S.2837, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017; H.R.2577/H.R.4974/S.2806, Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017; H.R.2028, Further Continuing and Security Assistance Appropriations Act, 2017 (P.L.114-254); advance the use of FDA-approved medicines to treat addiction in criminal justice and public health settings.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRADY | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| ELIZABETH ALYSON HART | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JAKE PERRY | — |
| STEVE TILTON | — |
| TODD MATTHEW WEISS | — |
| MATT WISE | — |
Health Issues HCR
Implementation of P.L.114-198, Comprehensive Addiction and Recovery Act of 2016; H.R.34, 21st Century Cures Act (P.L.114-255); confronting the opioid and mental illness epidemic.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRADY | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| ELIZABETH ALYSON HART | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JAKE PERRY | — |
| STEVE TILTON | — |
| TODD MATTHEW WEISS | — |
| MATT WISE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.